Prognostic characteristics of MACC1 expression in epithelial ovarian cancer

Hoiseon Jeong, Jiyoon Jung, Hwa Eun Oh, Jung-Woo Choi, Eung Seok Lee, Young Sik Kim, Ju-Han Lee

Research output: Contribution to journalArticle

Abstract

Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 – 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 – 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.

Original languageEnglish
Article number9207153
JournalBioMed Research International
Volume2018
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Colonic Neoplasms
Neoplasm Metastasis
Messenger RNA
Hazards
Biomarkers
Confidence Intervals
Survival
Disease-Free Survival
Ovarian epithelial cancer
Epithelium
Databases
Neoplasms

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Prognostic characteristics of MACC1 expression in epithelial ovarian cancer. / Jeong, Hoiseon; Jung, Jiyoon; Oh, Hwa Eun; Choi, Jung-Woo; Lee, Eung Seok; Kim, Young Sik; Lee, Ju-Han.

In: BioMed Research International, Vol. 2018, 9207153, 01.01.2018.

Research output: Contribution to journalArticle

@article{1332dceb7b0c4af18aaea8b059fc1fef,
title = "Prognostic characteristics of MACC1 expression in epithelial ovarian cancer",
abstract = "Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95{\%} confidence interval (CI): 1.21 – 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95{\%} CI: 1.24 – 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.",
author = "Hoiseon Jeong and Jiyoon Jung and Oh, {Hwa Eun} and Jung-Woo Choi and Lee, {Eung Seok} and Kim, {Young Sik} and Ju-Han Lee",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/9207153",
language = "English",
volume = "2018",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Prognostic characteristics of MACC1 expression in epithelial ovarian cancer

AU - Jeong, Hoiseon

AU - Jung, Jiyoon

AU - Oh, Hwa Eun

AU - Choi, Jung-Woo

AU - Lee, Eung Seok

AU - Kim, Young Sik

AU - Lee, Ju-Han

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 – 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 – 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.

AB - Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 – 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 – 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.

UR - http://www.scopus.com/inward/record.url?scp=85062824514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062824514&partnerID=8YFLogxK

U2 - 10.1155/2018/9207153

DO - 10.1155/2018/9207153

M3 - Article

VL - 2018

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 9207153

ER -